Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
  1. 4 Shares withheld for taxes President gave up 316 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Legal Officer gave up 113 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 533 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Legal Officer gave up 533 shares (to pay taxes)
  5. 4 Shares withheld for taxes President gave up 990 shares (to pay taxes)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Exercise or conversion Director acquired 677 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 4 Exercise or conversion Director acquired 979 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 892 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 979 shares (option exercise)
  13. 4 Derivatives Options or other derivatives
  14. 4 Shares withheld for taxes Chief Financial Officer gave up 703 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Legal Officer gave up 551 shares (to pay taxes)
  16. 4 Open-market buy Chief Executive Officer bought 160,314 shares at an average $31.22 ($5,004,318)
  17. 4 Open-market buy Director bought 31,620 shares at $31.76 ($1,004,251)
  18. 4 Shares withheld for taxes Chief Financial Officer gave up 160 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Legal Officer gave up 273 shares (to pay taxes)
  20. 4 Shares withheld for taxes President gave up 612 shares (to pay taxes)

Page 5 of 54 · 1,067 filings